vs

Side-by-side financial comparison of CSW INDUSTRIALS, INC. (CSW) and NATURES SUNSHINE PRODUCTS INC (NATR). Click either name above to swap in a different company.

CSW INDUSTRIALS, INC. is the larger business by last-quarter revenue ($233.0M vs $123.8M, roughly 1.9× NATURES SUNSHINE PRODUCTS INC). CSW INDUSTRIALS, INC. runs the higher net margin — 4.4% vs 3.3%, a 1.1% gap on every dollar of revenue. On growth, CSW INDUSTRIALS, INC. posted the faster year-over-year revenue change (20.3% vs 4.7%). CSW INDUSTRIALS, INC. produced more free cash flow last quarter ($22.7M vs $7.6M). Over the past eight quarters, NATURES SUNSHINE PRODUCTS INC's revenue compounded faster (5.6% CAGR vs 5.1%).

Nature's Sunshine Products, Inc. also known as "NSP", is a manufacturer of dietary supplements, including herbs, vitamins, minerals, and personal care products. It is based in Lehi, Utah, with a manufacturing facility in Spanish Fork, Utah.

CSW vs NATR — Head-to-Head

Bigger by revenue
CSW
CSW
1.9× larger
CSW
$233.0M
$123.8M
NATR
Growing faster (revenue YoY)
CSW
CSW
+15.6% gap
CSW
20.3%
4.7%
NATR
Higher net margin
CSW
CSW
1.1% more per $
CSW
4.4%
3.3%
NATR
More free cash flow
CSW
CSW
$15.2M more FCF
CSW
$22.7M
$7.6M
NATR
Faster 2-yr revenue CAGR
NATR
NATR
Annualised
NATR
5.6%
5.1%
CSW

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
CSW
CSW
NATR
NATR
Revenue
$233.0M
$123.8M
Net Profit
$10.3M
$4.1M
Gross Margin
39.7%
72.5%
Operating Margin
7.4%
4.3%
Net Margin
4.4%
3.3%
Revenue YoY
20.3%
4.7%
Net Profit YoY
-61.9%
1379.4%
EPS (diluted)
$0.62
$0.23

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CSW
CSW
NATR
NATR
Q4 25
$233.0M
$123.8M
Q3 25
$277.0M
$128.3M
Q2 25
$263.6M
$114.8M
Q1 25
$230.5M
$113.2M
Q4 24
$193.6M
$118.2M
Q3 24
$227.9M
$114.6M
Q2 24
$226.2M
$110.6M
Q1 24
$210.9M
$111.0M
Net Profit
CSW
CSW
NATR
NATR
Q4 25
$10.3M
$4.1M
Q3 25
$40.7M
$5.3M
Q2 25
$40.9M
$5.3M
Q1 25
$35.1M
$4.7M
Q4 24
$26.9M
$-321.0K
Q3 24
$36.1M
$4.3M
Q2 24
$38.6M
$1.3M
Q1 24
$31.8M
$2.3M
Gross Margin
CSW
CSW
NATR
NATR
Q4 25
39.7%
72.5%
Q3 25
43.0%
73.3%
Q2 25
43.8%
71.7%
Q1 25
44.2%
72.1%
Q4 24
41.4%
72.0%
Q3 24
45.6%
71.3%
Q2 24
47.5%
71.4%
Q1 24
44.4%
71.2%
Operating Margin
CSW
CSW
NATR
NATR
Q4 25
7.4%
4.3%
Q3 25
20.5%
7.0%
Q2 25
20.8%
3.7%
Q1 25
19.5%
5.4%
Q4 24
15.3%
3.8%
Q3 24
22.6%
4.6%
Q2 24
24.3%
5.1%
Q1 24
21.0%
4.2%
Net Margin
CSW
CSW
NATR
NATR
Q4 25
4.4%
3.3%
Q3 25
14.7%
4.2%
Q2 25
15.5%
4.6%
Q1 25
15.2%
4.2%
Q4 24
13.9%
-0.3%
Q3 24
15.8%
3.8%
Q2 24
17.1%
1.2%
Q1 24
15.1%
2.1%
EPS (diluted)
CSW
CSW
NATR
NATR
Q4 25
$0.62
$0.23
Q3 25
$2.41
$0.30
Q2 25
$2.43
$0.28
Q1 25
$2.05
$0.25
Q4 24
$1.60
$-0.02
Q3 24
$2.26
$0.23
Q2 24
$2.47
$0.07
Q1 24
$2.03
$0.12

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CSW
CSW
NATR
NATR
Cash + ST InvestmentsLiquidity on hand
$40.2M
$93.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$1.1B
$161.6M
Total Assets
$2.3B
$261.1M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CSW
CSW
NATR
NATR
Q4 25
$40.2M
$93.9M
Q3 25
$31.5M
$95.6M
Q2 25
$38.0M
$81.3M
Q1 25
$225.8M
$86.5M
Q4 24
$213.8M
$84.7M
Q3 24
$273.2M
$78.7M
Q2 24
$18.9M
$68.7M
Q1 24
$22.2M
$77.8M
Total Debt
CSW
CSW
NATR
NATR
Q4 25
Q3 25
Q2 25
Q1 25
$800.1M
Q4 24
Q3 24
Q2 24
Q1 24
$166.0M
$2.1M
Stockholders' Equity
CSW
CSW
NATR
NATR
Q4 25
$1.1B
$161.6M
Q3 25
$1.1B
$166.7M
Q2 25
$1.1B
$163.7M
Q1 25
$1.1B
$167.1M
Q4 24
$1.0B
$161.0M
Q3 24
$1.0B
$162.6M
Q2 24
$650.2M
$156.4M
Q1 24
$615.7M
$159.7M
Total Assets
CSW
CSW
NATR
NATR
Q4 25
$2.3B
$261.1M
Q3 25
$1.5B
$264.8M
Q2 25
$1.5B
$254.9M
Q1 25
$1.4B
$252.7M
Q4 24
$1.4B
$240.9M
Q3 24
$1.4B
$245.3M
Q2 24
$1.1B
$235.8M
Q1 24
$1.0B
$247.3M
Debt / Equity
CSW
CSW
NATR
NATR
Q4 25
Q3 25
Q2 25
Q1 25
0.75×
Q4 24
Q3 24
Q2 24
Q1 24
0.27×
0.01×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CSW
CSW
NATR
NATR
Operating Cash FlowLast quarter
$28.9M
$9.9M
Free Cash FlowOCF − Capex
$22.7M
$7.6M
FCF MarginFCF / Revenue
9.8%
6.1%
Capex IntensityCapex / Revenue
2.6%
1.9%
Cash ConversionOCF / Net Profit
2.81×
2.41×
TTM Free Cash FlowTrailing 4 quarters
$162.0M
$28.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CSW
CSW
NATR
NATR
Q4 25
$28.9M
$9.9M
Q3 25
$61.8M
$18.5M
Q2 25
$60.6M
$4.3M
Q1 25
$27.3M
$2.6M
Q4 24
$11.6M
$12.2M
Q3 24
$66.8M
$9.6M
Q2 24
$62.7M
$1.3M
Q1 24
$22.4M
$2.2M
Free Cash Flow
CSW
CSW
NATR
NATR
Q4 25
$22.7M
$7.6M
Q3 25
$58.7M
$16.8M
Q2 25
$57.7M
$3.0M
Q1 25
$22.8M
$1.5M
Q4 24
$8.5M
$10.0M
Q3 24
$61.3M
$7.9M
Q2 24
$59.6M
$-2.0M
Q1 24
$17.5M
$-1.5M
FCF Margin
CSW
CSW
NATR
NATR
Q4 25
9.8%
6.1%
Q3 25
21.2%
13.1%
Q2 25
21.9%
2.6%
Q1 25
9.9%
1.3%
Q4 24
4.4%
8.5%
Q3 24
26.9%
6.9%
Q2 24
26.3%
-1.9%
Q1 24
8.3%
-1.4%
Capex Intensity
CSW
CSW
NATR
NATR
Q4 25
2.6%
1.9%
Q3 25
1.1%
1.3%
Q2 25
1.1%
1.2%
Q1 25
2.0%
1.0%
Q4 24
1.6%
1.9%
Q3 24
2.4%
1.5%
Q2 24
1.4%
3.0%
Q1 24
2.3%
3.3%
Cash Conversion
CSW
CSW
NATR
NATR
Q4 25
2.81×
2.41×
Q3 25
1.52×
3.46×
Q2 25
1.48×
0.81×
Q1 25
0.78×
0.55×
Q4 24
0.43×
Q3 24
1.85×
2.21×
Q2 24
1.62×
0.97×
Q1 24
0.71×
0.94×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CSW
CSW

Contractor Solutions Segment$166.3M71%
Specialized Reliability Solutions Segment$38.2M16%
Engineered Building Solutions Segment$28.5M12%

NATR
NATR

Other$68.1M55%
General Health Products$20.2M16%
Digestive Products$13.8M11%
Cardiovascular Products$12.1M10%
Personal Care Products$4.4M4%
Immunity Products$3.1M3%
Weight Management Products$2.1M2%

Related Comparisons